101 related articles for article (PubMed ID: 1803611)
21. Concomitant reduction of disease activity and IL-10 secreting peripheral blood mononuclear cells during immunoadsorption in patients with active systenic lupus erythematosus.
Willeke P; Schotte H; Erren M; Schlüther B; Mickholz E; Domschke W; Gaubitz M
Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):323-9. PubMed ID: 12030438
[TBL] [Abstract][Full Text] [Related]
22. Up-regulation of TRAIL mRNA expression in peripheral blood mononuclear cells from patients with active systemic lupus erythematosus.
Komatsuda A; Wakui H; Iwamoto K; Togashi M; Maki N; Masai R; Hatakeyama T; Sawada K
Clin Immunol; 2007 Oct; 125(1):26-9. PubMed ID: 17683987
[TBL] [Abstract][Full Text] [Related]
23. MX homologous protein in mononuclear cells from patients with systemic lupus erythematosus.
von Wussow P; Jakschies D; Hochkeppel H; Horisberger M; Hartung K; Deicher H
Arthritis Rheum; 1989 Jul; 32(7):914-8. PubMed ID: 2751723
[TBL] [Abstract][Full Text] [Related]
24. [Abnormal signaling activity of phosphatidylinositol 3-kinase pathway in peripheral blood T cells from patients with systemic lupus erythematosus].
Liang LQ; Zhan ZP; Xu HS; Yang XY; Ye YJ; Lian F; Qiu Q
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(29):2036-40. PubMed ID: 19080430
[TBL] [Abstract][Full Text] [Related]
25. [Prednisolone sensitivity of peripheral blood mononuclear cells of patients with systemic lupus erythematosus clinically resistant to glucocorticoids and the effects of carbon hemoperfusion].
Petrova GN; Baranova FS; Popova LK; Dmitriev AA
Ter Arkh; 1987; 59(8):107-10. PubMed ID: 3686432
[TBL] [Abstract][Full Text] [Related]
26. B lymphocyte stimulator overexpression in patients with systemic lupus erythematosus: longitudinal observations.
Stohl W; Metyas S; Tan SM; Cheema GS; Oamar B; Xu D; Roschke V; Wu Y; Baker KP; Hilbert DM
Arthritis Rheum; 2003 Dec; 48(12):3475-86. PubMed ID: 14673998
[TBL] [Abstract][Full Text] [Related]
27. Elevated expression of the Brn-3a and Brn-3b transcription factors in systemic lupus erythematosus correlates with antibodies to Brn-3 and overexpression of Hsp90.
Ripley BJ; Rahman MA; Isenberg DA; Latchman DS
Arthritis Rheum; 2005 Apr; 52(4):1171-9. PubMed ID: 15818685
[TBL] [Abstract][Full Text] [Related]
28. [Clinical value of determining beta-glucuronidase and glycosaminoglycans in blood cells and biological fluids in patients with rheumatoid arthritis].
Astakhova TA; Volkova ZI; Trofimova TM; Mul'diiarov PIa
Ter Arkh; 1987; 59(4):62-7. PubMed ID: 3590007
[TBL] [Abstract][Full Text] [Related]
29. Telomerase activity in peripheral blood mononuclear cells of systemic connective tissue diseases.
Katayama Y; Kohriyama K
J Rheumatol; 2001 Feb; 28(2):288-91. PubMed ID: 11246663
[TBL] [Abstract][Full Text] [Related]
30. Up-regulation of cellular FLICE-inhibitory protein in peripheral blood B lymphocytes in patients with systemic lupus erythematosus is associated with clinical characteristics.
Tao J; Dong J; Li Y; Liu YQ; Yang J; Wu Y; Li L; Shen GX; Tan ZJ; Tu YT
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):433-7. PubMed ID: 19335730
[TBL] [Abstract][Full Text] [Related]
31. The reduction of serum B-lymphocyte activating factor levels following quinacrine add-on therapy in systemic lupus erythematosus.
Toubi E; Kessel A; Rosner I; Rozenbaum M; Paran D; Shoenfeld Y
Scand J Immunol; 2006 Apr; 63(4):299-303. PubMed ID: 16623930
[TBL] [Abstract][Full Text] [Related]
32. Apoptosis of lymphocytes induced by glucocorticoids and relationship to therapeutic efficacy in patients with systemic lupus erythematosus.
Seki M; Ushiyama C; Seta N; Abe K; Fukazawa T; Asakawa J; Takasaki Y; Hashimoto H
Arthritis Rheum; 1998 May; 41(5):823-30. PubMed ID: 9588733
[TBL] [Abstract][Full Text] [Related]
33. FCgammaRII (CD32)-dependent induction of interferon-alpha by serum from patients with lupus erythematosus.
Batteux F; Palmer P; Daëron M; Weill B; Lebon P
Eur Cytokine Netw; 1999 Dec; 10(4):509-14. PubMed ID: 10586117
[TBL] [Abstract][Full Text] [Related]
34. Serum cytidine deaminase as a measure of disease activity in rheumatoid arthritis and systemic lupus erythematosus.
Skeith KJ; Wefuan J; Oswald R; Davis P
J Rheumatol; 1993 Aug; 20(8):1309-15. PubMed ID: 8230010
[TBL] [Abstract][Full Text] [Related]
35. Reduction of bcl-2 in T cells during immunosuppressive therapy in patients with severe juvenile onset systemic lupus erythematosus.
Falcini F; Azzari C; Gelli VA; Luchetti M; Gabrielli A; Calzolari A; Pignone A; Generini S; Matucci Cerinic M
Clin Immunol; 1999 Oct; 93(1):59-64. PubMed ID: 10497011
[TBL] [Abstract][Full Text] [Related]
36. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
Yajima N; Kasama T; Isozaki T; Odai T; Matsunawa M; Negishi M; Ide H; Kameoka Y; Hirohata S; Adachi M
Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
[TBL] [Abstract][Full Text] [Related]
37. Signals of monocyte activation in patients with SLE.
Kávai M; Zsindely A; Sonkoly I; Major M; Demján I; Szegedi G
Clin Exp Immunol; 1983 Feb; 51(2):255-60. PubMed ID: 6839541
[TBL] [Abstract][Full Text] [Related]
38. [Glycosaminoglycans and beta-glucuronidase in peripheral blood cells and biological fluids of patients with rheumatoid arthritis].
Volkova ZI; Astakhova TA; Trofimova TM; Mul'diiarov PIa
Vopr Med Khim; 1988; 34(3):53-9. PubMed ID: 3420812
[TBL] [Abstract][Full Text] [Related]
39. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus.
Mahmoud RA; El-Gendi HI; Ahmed HH
Clin Biochem; 2005 Feb; 38(2):134-41. PubMed ID: 15642275
[TBL] [Abstract][Full Text] [Related]
40. Monocyte procoagulant activity in glomerulonephritis associated with systemic lupus erythematosus.
Cole EH; Schulman J; Urowitz M; Keystone E; Williams C; Levy GA
J Clin Invest; 1985 Mar; 75(3):861-8. PubMed ID: 4038982
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
